Sfoglia per Autore
Neoadjuvant chemo-radiotherapy for locally advanced esophageal cancer: a monocentric study.
2012-01-01 Schena M; La Rovere E; Solerio D; Bustreo S; Barone C; Daniele L; Buffoni L; Bironzo P; Sapino A; Gasparri G; Ciuffreda L; Ricardi U.
DNA repair gene expression level in peripheral blood and tumour tissue from non-small cell lung cancer and head and neck squamous cell cancer patients.
2012-01-01 Schena M; Guarrera S; Buffoni L; Salvadori A; Voglino F; Allione A; Pecorari G; Ruffini E; Garzino-Demo P; Bustreo S; Consito L; Bironzo P; Matullo G.
Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone.
2013-01-01 Pia, Anna; Vignani, Francesca; Attard, Gerhardt; Tucci, Marcello; Bironzo, Paolo; Scagliotti, Giorgio; Arlt, Wiebke; Terzolo, Massimo; Berruti, Alfredo*
Squamous carcinoma of the lung: Still a long and winding road to successful treatment
2014-01-01 Bironzo, Paolo*; Scagliotti, Giorgio Vittorio
Moving from histological subtyping to molecular characterization: new treatment opportunities in advanced non-small-cell lung cancer
2014-01-01 Simona Carnio;Silvia Novello;Paolo Bironzo;Giorgio Vittorio Scagliotti
Advanced non-small cell lung cancer in elderly patients: A review
2015-01-01 Buffoni, Lucio; Consito, Lorena; Filippi, Andrea Riccardo; Ruffini, Enrico; Solidoro, Paolo; Bironzo, Paolo; Satolli, Maria Antonietta; Schena, Marina; Ciuffreda, Libero
Chapter 17, Achievements in Targeted Therapies - ERS Monographs - Lung Cancer
2015-01-01 Bironzo Paolo; Mele Teresa; Novello Silvia
How to personalize perioperative chemotherapy in early non-small cell lung cancer?
2015-01-01 Carnio, S., Bironzo, P., Novello, S., Scagliotti, G.V.
Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study.
2015-01-01 Lo Iacono M;Monica V;Righi L;Grosso F;Libener R;Vatrano S;Bironzo P;Novello S;Musmeci L;Volante M;Papotti M;Scagliotti GV
Addressing the unmet need in lung cancer: The potential of immuno-oncology
2015-01-01 Scagliotti, G.V; Bironzo, P.; Vansteenkiste, J.F.
Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer
2015-01-01 Buttigliero, Consuelo; Tucci, Marcello; Bertaglia, Valentina; Vignani, Francesca; Bironzo, Paolo; Di Maio, Massimo; Scagliotti, Giorgio Vittorio
MET exon 14 mutation: Another actionable genomic variation in patients with advanced NSCLC
2016-01-01 Di Maio, Massimo; Bironzo, Paolo; Scagliotti, Giorgio Vittorio*
Raising the bar for enthusiasm when looking at results of randomized phase II trials-The case of sunitinib in small-cell lung cancer
2016-01-01 Di Maio, Massimo; Bironzo, Paolo; Scagliotti, Giorgio Vittorio
C28Sequencing cabazitaxel and new generation hormonal treatments in metastatic castration resistant prostate cancer patients after first line docetaxel: a retrospective analysis
2016-01-01 Tucci, M.; Buttigliero, C.; Vignani, F.; Iaconis, D.; Bertaglia, V.; Bironzo, P.; Pignataro, D.; Scagliotti, G.V.; Di Maio, M.
Pathogenesis, clinical manifestations and management of immune checkpoint inhibitors toxicity
2017-01-01 Inno, Alessandro; Metro, Giulio; Bironzo, Paolo; Grimaldi, Antonio M; Grego, Elisabetta; Nunno, Vincenzo Di; Picasso, Virginia; Massari, Francesco; Gori, Stefania*
Surrogate Endpoints in Second-Line Trials of Targeted Agents in Metastatic Colorectal Cancer: A Literature-Based Systematic Review and Meta-Analysis
2017-01-01 Cremolini, Chiara; Antoniotti, Carlotta; Pietrantonio, Filippo; Berenato, Rosa; Tampellini, Marco; Baratelli, Chiara; Salvatore, Lisa; Marmorino, Federica; Borelli, Beatrice; Nichetti, Federico; Bironzo, Paolo; Sonetto, Cristina; Bartolomeo, Maria Di; de Braud, Filippo; Loupakis, Fotios; Falcone, Alfredo; Di Maio, Massimo
Osimertinib-induced Cardiac Dysfunction in EGFRMutated Lung Cancer: A Case Series of Five Patients
2018-01-01 Maria Lucia Reale, Matteo Bianco, Fabrizio Tabbò, Annapaola Mariniello, Paola Destefanis, Alessia Luciano, Paolo Bironzo, Simona Carnio, Enrica Capelletto, Roberto Pozzi, Silvia Novello
Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysis
2018-01-01 Di Maio, Massimo; Baratelli, Chiara; Bironzo, Paolo; Vignani, Francesca; Bria, Emilio; Sperti, Elisa; Marcato, Maddalena; Roila, Fausto
Thymidine phosphorylase: The unforeseen driver in colorectal cancer treatment?
2018-01-01 Tampellini, Marco*; Bironzo, Paolo; Di Maio, Massimo; Scagliotti, Giorgio V
NIBIT-MESO-1: Limitations and clinical perspectives in MPM treatment testing an immune checkpoint blockade combination in a single-arm study
2018-01-01 Bironzo, Paolo; Taulli, Riccardo*
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Neoadjuvant chemo-radiotherapy for locally advanced esophageal cancer: a monocentric study. | 2012 | Schena M; La Rovere E; Solerio D; Bustreo S; Barone C; Daniele L; Buffoni L; Bironzo P; Sapino A; Gasparri G; Ciuffreda L; Ricardi U. | |
| DNA repair gene expression level in peripheral blood and tumour tissue from non-small cell lung cancer and head and neck squamous cell cancer patients. | 2012 | Schena M; Guarrera S; Buffoni L; Salvadori A; Voglino F; Allione A; Pecorari G; Ruffini E; Garzino-Demo P; Bustreo S; Consito L; Bironzo P; Matullo G. | |
| Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone. | 2013 | Pia, Anna; Vignani, Francesca; Attard, Gerhardt; Tucci, Marcello; Bironzo, Paolo; Scagliotti, Giorgio; Arlt, Wiebke; Terzolo, Massimo; Berruti, Alfredo* | |
| Squamous carcinoma of the lung: Still a long and winding road to successful treatment | 2014 | Bironzo, Paolo*; Scagliotti, Giorgio Vittorio | |
| Moving from histological subtyping to molecular characterization: new treatment opportunities in advanced non-small-cell lung cancer | 2014 | Simona Carnio;Silvia Novello;Paolo Bironzo;Giorgio Vittorio Scagliotti | |
| Advanced non-small cell lung cancer in elderly patients: A review | 2015 | Buffoni, Lucio; Consito, Lorena; Filippi, Andrea Riccardo; Ruffini, Enrico; Solidoro, Paolo; Bironzo, Paolo; Satolli, Maria Antonietta; Schena, Marina; Ciuffreda, Libero | |
| Chapter 17, Achievements in Targeted Therapies - ERS Monographs - Lung Cancer | 2015 | Bironzo Paolo; Mele Teresa; Novello Silvia | |
| How to personalize perioperative chemotherapy in early non-small cell lung cancer? | 2015 | Carnio, S., Bironzo, P., Novello, S., Scagliotti, G.V. | |
| Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study. | 2015 | Lo Iacono M;Monica V;Righi L;Grosso F;Libener R;Vatrano S;Bironzo P;Novello S;Musmeci L;Volante M;Papotti M;Scagliotti GV | |
| Addressing the unmet need in lung cancer: The potential of immuno-oncology | 2015 | Scagliotti, G.V; Bironzo, P.; Vansteenkiste, J.F. | |
| Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer | 2015 | Buttigliero, Consuelo; Tucci, Marcello; Bertaglia, Valentina; Vignani, Francesca; Bironzo, Paolo; Di Maio, Massimo; Scagliotti, Giorgio Vittorio | |
| MET exon 14 mutation: Another actionable genomic variation in patients with advanced NSCLC | 2016 | Di Maio, Massimo; Bironzo, Paolo; Scagliotti, Giorgio Vittorio* | |
| Raising the bar for enthusiasm when looking at results of randomized phase II trials-The case of sunitinib in small-cell lung cancer | 2016 | Di Maio, Massimo; Bironzo, Paolo; Scagliotti, Giorgio Vittorio | |
| C28Sequencing cabazitaxel and new generation hormonal treatments in metastatic castration resistant prostate cancer patients after first line docetaxel: a retrospective analysis | 2016 | Tucci, M.; Buttigliero, C.; Vignani, F.; Iaconis, D.; Bertaglia, V.; Bironzo, P.; Pignataro, D.; Scagliotti, G.V.; Di Maio, M. | |
| Pathogenesis, clinical manifestations and management of immune checkpoint inhibitors toxicity | 2017 | Inno, Alessandro; Metro, Giulio; Bironzo, Paolo; Grimaldi, Antonio M; Grego, Elisabetta; Nunno, Vincenzo Di; Picasso, Virginia; Massari, Francesco; Gori, Stefania* | |
| Surrogate Endpoints in Second-Line Trials of Targeted Agents in Metastatic Colorectal Cancer: A Literature-Based Systematic Review and Meta-Analysis | 2017 | Cremolini, Chiara; Antoniotti, Carlotta; Pietrantonio, Filippo; Berenato, Rosa; Tampellini, Marco; Baratelli, Chiara; Salvatore, Lisa; Marmorino, Federica; Borelli, Beatrice; Nichetti, Federico; Bironzo, Paolo; Sonetto, Cristina; Bartolomeo, Maria Di; de Braud, Filippo; Loupakis, Fotios; Falcone, Alfredo; Di Maio, Massimo | |
| Osimertinib-induced Cardiac Dysfunction in EGFRMutated Lung Cancer: A Case Series of Five Patients | 2018 | Maria Lucia Reale, Matteo Bianco, Fabrizio Tabbò, Annapaola Mariniello, Paola Destefanis, Alessia Luciano, Paolo Bironzo, Simona Carnio, Enrica Capelletto, Roberto Pozzi, Silvia Novello | |
| Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysis | 2018 | Di Maio, Massimo; Baratelli, Chiara; Bironzo, Paolo; Vignani, Francesca; Bria, Emilio; Sperti, Elisa; Marcato, Maddalena; Roila, Fausto | |
| Thymidine phosphorylase: The unforeseen driver in colorectal cancer treatment? | 2018 | Tampellini, Marco*; Bironzo, Paolo; Di Maio, Massimo; Scagliotti, Giorgio V | |
| NIBIT-MESO-1: Limitations and clinical perspectives in MPM treatment testing an immune checkpoint blockade combination in a single-arm study | 2018 | Bironzo, Paolo; Taulli, Riccardo* |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile